scholarly article | Q13442814 |
P50 | author | Marion A Hofmann Bowman | Q83525326 |
P2093 | author name string | Elizabeth M McNally | |
P2860 | cites work | RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides | Q22010236 |
NT5E mutations and arterial calcifications | Q24607121 | ||
Myeloid-related protein-8/14 is critical for the biological response to vascular injury | Q24627504 | ||
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants | Q24645076 | ||
S100A8 and S100A9 in cardiovascular biology and disease | Q27024450 | ||
Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum | Q28250100 | ||
Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine | Q28505453 | ||
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice | Q30444108 | ||
Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum | Q30499841 | ||
Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation | Q30921329 | ||
Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel | Q33352008 | ||
Disruption of the aortic elastic lamina and medial calcification share genetic determinants in mice | Q33717822 | ||
The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature | Q33822512 | ||
Atherosclerosis in ancient Egyptian mummies: the Horus study. | Q33863379 | ||
S100A12 mediates aortic wall remodeling and aortic aneurysm | Q33883852 | ||
Calgranulin C has filariacidal and filariastatic activity | Q34002843 | ||
Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues | Q34042814 | ||
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial | Q34134664 | ||
Association of warfarin use with valvular and vascular calcification: a review. | Q34162996 | ||
Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification | Q34217171 | ||
Neuropilin-1 regulates a new VEGF-induced gene, Phactr-1, which controls tubulogenesis and modulates lamellipodial dynamics in human endothelial cells. | Q34218449 | ||
Aortic valve sclerosis as a marker of active atherosclerosis | Q34517427 | ||
Vascular remodeling and arterial calcification are directly mediated by S100A12 (EN-RAGE) in chronic kidney disease. | Q34724983 | ||
Matrix vesicles and calcification | Q35126667 | ||
Npp1 promotes atherosclerosis in ApoE knockout mice | Q35161110 | ||
S100/calgranulins EN-RAGEing the blood vessels: implications for inflammatory responses and atherosclerosis | Q35627729 | ||
Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6 | Q35671719 | ||
Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics | Q35721533 | ||
In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles. | Q35947472 | ||
S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program | Q35998253 | ||
Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction | Q36095771 | ||
S100A12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications | Q36173951 | ||
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. | Q36678487 | ||
Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients | Q37206902 | ||
Pseudoxanthoma elasticum: reduced gamma-glutamyl carboxylation of matrix gla protein in a mouse model (Abcc6-/-). | Q37237514 | ||
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study | Q37323326 | ||
Mechanisms and treatment of extraosseous calcification in chronic kidney disease | Q37902504 | ||
Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations | Q37977038 | ||
Arterial calcification is driven by RAGE in Enpp1-/- mice | Q41202872 | ||
Connective tissue mineralization in Abcc6-/- mice, a model for pseudoxanthoma elasticum | Q42141765 | ||
The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: a meta-analysis | Q43470272 | ||
Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults | Q44064953 | ||
Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension | Q44781121 | ||
Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients. | Q46415465 | ||
Receptor for advanced glycation end product polymorphisms and type 2 diabetes: the CODAM study | Q46850771 | ||
Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. | Q53248438 | ||
The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study. | Q53657481 | ||
The Functional -374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients | Q58793815 | ||
The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI) | Q81159927 | ||
Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis | Q82327200 | ||
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes | Q84183344 | ||
P433 | issue | 4 | |
P304 | page(s) | 93-98 | |
P577 | publication date | 2012-05-01 | |
P1433 | published in | Trends in Cardiovascular Medicine | Q1850265 |
P1476 | title | Genetic pathways of vascular calcification | |
P478 | volume | 22 |
Q63761477 | A materials science vision of extracellular matrix mineralization |
Q39071314 | Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications. |
Q46946207 | Arterial calcification due to CD73 deficiency (ACDC): imaging manifestations of ectopic mineralization |
Q38543758 | Arteriosclerosis and vascular calcification: causes, clinical assessment and therapy |
Q92535641 | Bavachin Protects Human Aortic Smooth Muscle Cells Against β-Glycerophosphate-Mediated Vascular Calcification and Apoptosis via Activation of mTOR-Dependent Autophagy and Suppression of β-Catenin Signaling |
Q38742857 | Clinical imaging of vascular disease in chronic kidney disease |
Q35677780 | Correlation of single nucleotide polymorphisms in the pregnancy-associated plasma protein-A gene with carotid plaques |
Q90046558 | Different histological types of active intraplaque calcification underlie alternative miRNA-mRNA axes in carotid atherosclerotic disease |
Q36222057 | Ectopic Mineralization and Conductive Hearing Loss in Enpp1asj Mutant Mice, a New Model for Otitis Media and Tympanosclerosis |
Q38193216 | Ectopic calcification in diabetic vascular disease. |
Q58790794 | Enzyme-modified non-oxidized LDL (ELDL) induces human coronary artery smooth muscle cell transformation to a migratory and osteoblast-like phenotype |
Q30301168 | Genetic determinants of arterial stiffness |
Q37426711 | Impaired fasting glucose and diabetes as predictors for radial artery calcification in end stage renal disease patients. |
Q94475260 | LncRNA H19/Runx2 axis promotes VSMCs transition via MAPK pathway |
Q47782108 | Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression. |
Q26778664 | Mechanisms of ectopic calcification: implications for diabetic vasculopathy |
Q30409314 | Medial vascular calcification revisited: review and perspectives |
Q51583712 | MicroRNA-34b/c inhibits aldosterone-induced vascular smooth muscle cell calcification via a SATB2/Runx2 pathway. |
Q41170142 | Osteocalcin, Vascular Calcification, and Atherosclerosis: A Systematic Review and Meta-analysis |
Q34669852 | Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. |
Q52571080 | Polymorphisms of Antioxidant Genes as a Target for Diabetes Management. |
Q37271191 | Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease. |
Q38238914 | RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy |
Q59341219 | S100/RAGE-Mediated Inflammation and Modified Cholesterol Lipoproteins as Mediators of Osteoblastic Differentiation of Vascular Smooth Muscle Cells |
Q36631781 | S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets |
Q37682494 | Systems Genetics Approach Identifies Gene Pathways and Adamts2 as Drivers of Isoproterenol-Induced Cardiac Hypertrophy and Cardiomyopathy in Mice |
Q34821047 | The mystery of persistent pulmonary hypertension: an idiopathic infantile arterial calcification |
Q96132710 | Vascular Calcification: An Important Understanding in Nephrology |
Q33646711 | Vascular Calcification: Current Genetics Underlying This Complex Phenomenon |
Q26851687 | Vascular calcification--is aldosterone a culprit? |
Search more.